BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ATLAS Biolabs GmbH Fulfills the DIN EN ISO 13485:2003 + AC: 2009 Standard for Designing and Manufacturing Medical Devices


5/11/2011 10:58:13 AM

Berlin, May 11, 2011 – By gaining certification according to the internationally recognized quality standard DIN EN ISO 13485 + AC:2009, ATLAS Biolabs GmbH has reached another milestone in its advances in the field of molecular diagnostics. DIN EN ISO 13485 + AC:2009 provides the criteria for quality management in the design and manufacture of medical devices; and compliance with this standard is required in order to develop and distribute software that falls within the scope of the European directive 98/79/EC for in vitro diagnostics. The new certificate gives the company a stronger position in molecular diagnostics and makes it an ideal partner for other companies that are looking to develop or have developed in vitro diagnostic tools. ATLAS Biolabs has been certified according to DIN EN ISO 9001 since 2008.

The newly acquired certification allows the company to develop a software-based expert system for evaluating chromosomal aberrations which will complement its existing genotyping and molecular karyotyping services. “The development of such an expert system is based on the experience we have gathered over many years in processing and analyzing hundreds of samples submitted by cytogenetic laboratories and academic institutions specialized in human genetic testing. From our discussions with physicians, we have understood that gathering, linking and interpreting all the information available is a laborious task and that such an expert system needs to be developed very carefully,“ said Peter Nürnberg, CEO of ATLAS Biolabs. ATLAS Biolabs’ new expert system will support physicians needing to evaluate the different kinds of information linked to aberrations that could be responsible for the observed phenotypes. It will also be subject to risk management according to ISO 14971:2007.

About ATLAS Biolabs GmbH

ATLAS Biolabs GmbH is a leading provider of complex analyses in molecular genetics, including microarray-based genomic services, targeted sequence capture and next-generation sequencing, in Europe. The company has access to the DNA chip platforms of all leading enterprises in this field (Affymetrix, Agilent, Illumina and Roche NimbleGen) and is a Certified Affymetrix, Agilent and Roche NimbleGen Service Provider. Based in Germany, ATLAS Biolabs started its business operations in August 2007. Its production processes are subjected to rigorous quality control at all steps in accordance with the international standards ISO 9001:2008 und ISO 13485:2003. Customers of ATLAS Biolabs include academic institutions, pharmaceutical and biotechnological enterprises, clinicians and registered physicians both in Germany and abroad. For more information, please go to www.atlas-biolabs.com.

Contact:

Mugele Kommunikation

Dr. Katrin Mugele

Phone: + 49 30 7816869

Fax: + 49 3212 7816869

E-mail: press@mugele-kommunikation.de

ATLAS Biolabs GmbH

Friedrichstr. 147 | 10117 Berlin, Germany

Registered Office: Cologne, Germany

Commercial Register: Amtsgericht Köln | HRB 59119

CEO: Prof. Dr. Peter Nürnberg

www.atlas-biolabs.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES